PTGS2 and gastric cancer: Interestingly, recent experiments in GC derived cells have shown a relationship between COX2 expression and the inhibition of the Glycogen Synthase Kinase-3β (GSK3β) enzyme [25], which is a key Wnt component that phosphorylates β-catenin and promotes its subsequent degradation via proteasome [26].